tirzepatide 2.5 mg 0.5 ml subcutaneous solution MOUNJARO 2.5MG ( FOR INJECTION 2.5MG / ) at ₹ 7000/vial | Tirzepatide Injection in Nagpur tirzepatide 2.5 mg/0.5 ml subcutaneous

From "Ozempic face" and dry skin to acne and hair loss, GLP-1 medications can bring unexpected changes to your skin, hair and overall appearance

Wegovy tablets have been approved by the MHRA on 11 June 2026 and are expected to be available by the 7th of July

A budget-first approach to expanding preventative weight health benefits without health plan shock.

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

Medical Weight Loss with Semaglutide Our medical weight loss programs are tailored to assist individuals facing challenges with conventional weight loss methods such as diet and exercise

Expanding global access to affordable metabolic care